Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Or taking a medication that later proved to have a rare side effect you could not have known about
GLP-1 receptor agonists typically reduce total cholesterol by 28%, LDL cholesterol by 36%, and triglycerides by 1015%
10.1016/j.physbeh.2012.04.004 10 BezinJ.GouverneurA.PnichonM.MathieuC.GarrelR.Hillaire-BuysD.et al (2023)
Research Characteristics: Synthetic analogue studied for GLP-1 receptor activity Examined for its influence on hormone signaling and receptor binding dynamics Utilized in laboratory research exploring pathways linked to endocrine and metabolic regulation THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only
This stabilizes the transcription factor BACH1, which subsequently upregulates angiogenesis-related factors, including PDGFB, EGFR, FGF2, and FGFR1, ultimately driving vascular regeneration
